1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Immune Globulins Revenue
1.4 Market Analysis by Type
1.4.1 Global Immune Globulins Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 IVIg Liquid
1.4.3 IVIg Powder
1.5 Market by Application
1.5.1 Global Immune Globulins Market Share by Application: 2021-2026
1.5.2 Immunodeficiency
1.5.3 Autoimmune Disease
1.5.4 Acute Infection
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Immune Globulins Market
1.8.1 Global Immune Globulins Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Immune Globulins Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Immune Globulins Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Immune Globulins Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Immune Globulins Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Immune Globulins Sales Volume Market Share by Region (2015-2020)
3.2 Global Immune Globulins Sales Revenue Market Share by Region (2015-2020)
3.3 North America Immune Globulins Sales Volume
3.3.1 North America Immune Globulins Sales Volume Growth Rate (2015-2020)
3.3.2 North America Immune Globulins Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Immune Globulins Sales Volume
3.4.1 East Asia Immune Globulins Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Immune Globulins Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Immune Globulins Sales Volume (2015-2020)
3.5.1 Europe Immune Globulins Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Immune Globulins Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Immune Globulins Sales Volume (2015-2020)
3.6.1 South Asia Immune Globulins Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Immune Globulins Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Immune Globulins Sales Volume (2015-2020)
3.7.1 Southeast Asia Immune Globulins Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Immune Globulins Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Immune Globulins Sales Volume (2015-2020)
3.8.1 Middle East Immune Globulins Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Immune Globulins Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Immune Globulins Sales Volume (2015-2020)
3.9.1 Africa Immune Globulins Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Immune Globulins Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Immune Globulins Sales Volume (2015-2020)
3.10.1 Oceania Immune Globulins Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Immune Globulins Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Immune Globulins Sales Volume (2015-2020)
3.11.1 South America Immune Globulins Sales Volume Growth Rate (2015-2020)
3.11.2 South America Immune Globulins Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Immune Globulins Sales Volume (2015-2020)
3.12.1 Rest of the World Immune Globulins Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Immune Globulins Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Immune Globulins Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Immune Globulins Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Immune Globulins Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Immune Globulins Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Immune Globulins Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Immune Globulins Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Immune Globulins Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Immune Globulins Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Immune Globulins Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Immune Globulins Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Immune Globulins Sales Volume Market Share by Type (2015-2020)
14.2 Global Immune Globulins Sales Revenue Market Share by Type (2015-2020)
14.3 Global Immune Globulins Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Immune Globulins Consumption Volume by Application (2015-2020)
15.2 Global Immune Globulins Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Immune Globulins Business
16.1 Baxter
16.1.1 Baxter Company Profile
16.1.2 Baxter Immune Globulins Product Specification
16.1.3 Baxter Immune Globulins Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 CNBG
16.2.1 CNBG Company Profile
16.2.2 CNBG Immune Globulins Product Specification
16.2.3 CNBG Immune Globulins Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Octapharma
16.3.1 Octapharma Company Profile
16.3.2 Octapharma Immune Globulins Product Specification
16.3.3 Octapharma Immune Globulins Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Grifols
16.4.1 Grifols Company Profile
16.4.2 Grifols Immune Globulins Product Specification
16.4.3 Grifols Immune Globulins Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Hualan Bio
16.5.1 Hualan Bio Company Profile
16.5.2 Hualan Bio Immune Globulins Product Specification
16.5.3 Hualan Bio Immune Globulins Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 CSL
16.6.1 CSL Company Profile
16.6.2 CSL Immune Globulins Product Specification
16.6.3 CSL Immune Globulins Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 CBPO
16.7.1 CBPO Company Profile
16.7.2 CBPO Immune Globulins Product Specification
16.7.3 CBPO Immune Globulins Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Kedrion
16.8.1 Kedrion Company Profile
16.8.2 Kedrion Immune Globulins Product Specification
16.8.3 Kedrion Immune Globulins Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Biotest
16.9.1 Biotest Company Profile
16.9.2 Biotest Immune Globulins Product Specification
16.9.3 Biotest Immune Globulins Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 Shanghai RAAS
16.10.1 Shanghai RAAS Company Profile
16.10.2 Shanghai RAAS Immune Globulins Product Specification
16.10.3 Shanghai RAAS Immune Globulins Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 LFB Group
16.11.1 LFB Group Company Profile
16.11.2 LFB Group Immune Globulins Product Specification
16.11.3 LFB Group Immune Globulins Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.12 BPL
16.12.1 BPL Company Profile
16.12.2 BPL Immune Globulins Product Specification
16.12.3 BPL Immune Globulins Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.13 Sichuan Yuanda Shuyang
16.13.1 Sichuan Yuanda Shuyang Company Profile
16.13.2 Sichuan Yuanda Shuyang Immune Globulins Product Specification
16.13.3 Sichuan Yuanda Shuyang Immune Globulins Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Immune Globulins Manufacturing Cost Analysis
17.1 Immune Globulins Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Immune Globulins
17.4 Immune Globulins Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Immune Globulins Distributors List
18.3 Immune Globulins Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Immune Globulins (2021-2026)
20.2 Global Forecasted Revenue of Immune Globulins (2021-2026)
20.3 Global Forecasted Price of Immune Globulins (2015-2026)
20.4 Global Forecasted Production of Immune Globulins by Region (2021-2026)
20.4.1 North America Immune Globulins Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Immune Globulins Production, Revenue Forecast (2021-2026)
20.4.3 Europe Immune Globulins Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Immune Globulins Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Immune Globulins Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Immune Globulins Production, Revenue Forecast (2021-2026)
20.4.7 Africa Immune Globulins Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Immune Globulins Production, Revenue Forecast (2021-2026)
20.4.9 South America Immune Globulins Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Immune Globulins Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Immune Globulins by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Immune Globulins by Country
21.2 East Asia Market Forecasted Consumption of Immune Globulins by Country
21.3 Europe Market Forecasted Consumption of Immune Globulins by Countriy
21.4 South Asia Forecasted Consumption of Immune Globulins by Country
21.5 Southeast Asia Forecasted Consumption of Immune Globulins by Country
21.6 Middle East Forecasted Consumption of Immune Globulins by Country
21.7 Africa Forecasted Consumption of Immune Globulins by Country
21.8 Oceania Forecasted Consumption of Immune Globulins by Country
21.9 South America Forecasted Consumption of Immune Globulins by Country
21.10 Rest of the world Forecasted Consumption of Immune Globulins by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer